SPY391.77+4.27 1.10%
DIA319.53+4.14 1.31%
IXIC13,597.97+132.77 0.99%

DJ Johnson & Johnson Seeks Emergency Use Vaccine Authorization

· 02/04/2021 18:15
By Stephen Nakrosis

Johnson & Johnson on Thursday said it submitted an application seeking emergency use authorization for its investigational single-dose Covid-19 vaccine candidate to the U.S. Food and Drug Administration.

The company also said it is ready to begin shipping the product upon authorization for emergency use, adding it "expects to supply 100 million doses to the U.S. in the first half of 2021."

(END) Dow Jones Newswires

February 04, 2021 18:15 ET (23:15 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.